Colorectal goblet cell sialomucin heterogeneity: its relation to malignant disease.

Por Sugihara, K, Jass, J R
Publicado em 1986

Colorectal goblet cell mucins in familial adenomatous polyposis.

Por Sugihara, K, Jass, J R
Publicado em 1987

Motility study in right sided diverticular disease of the colon.

Por Sugihara, K, Muto, T, Morioka, Y
Publicado em 1983

Basis of sialic acid heterogeneity in ulcerative colitis.

Por Jass, J R, Sugihara, K, Love, S B
Publicado em 1988

Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.

Por Yamamoto, J, Sugihara, K, Kosuge, T, Takayama, T, Shimada, K, Yamasaki, S, Sakamoto, M, Hirohashi, S
Publicado em 1995

Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence

Por Hamada, T, Matsukita, S, Goto, M, Kitajima, S, Batra, S K, Irimura, T, Sueyoshi, K, Sugihara, K, Yonezawa, S
Publicado em 2004

Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cells.

Por Nakamura, A, Sone, S, Nabioullin, R, Sugihara, K, Munekata, M, Nishioka, Y, Nii, A, Ogura, T
Publicado em 1993

Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer

Por Inokuchi, M, Yamashita, T, Yamada, H, Kojima, K, Ichikawa, W, Nihei, Z, Kawano, T, Sugihara, K
Publicado em 2006

Relation between outcomes and localisation of p-mTOR expression in gastric cancer

Por Murayama, T, Inokuchi, M, Takagi, Y, Yamada, H, Kojima, K, Kumagai, J, Kawano, T, Sugihara, K
Publicado em 2009

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for meta...

Por Ichikawa, W, Uetake, H, Shirota, Y, Yamada, H, Takahashi, T, Nihei, Z, Sugihara, K, Sasaki, Y, Hirayama, R
Publicado em 2003

Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis

Por Sugihara, K., Kobayashi, Y., Suzuki, A., Tamura, N., Motamedchaboki, K., Huang, C.-T., Akama, T.O., Pecotte, J., Frost, P., Bauer, C., Jimenez, J.B., Nakayama, J., Aoki, D., Fukuda, M.N.
Publicado em 2014

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

Por Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Publicado em 2012

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

Por Yoshida, M., Ishiguro, M., Ikejiri, K., Mochizuki, I., Nakamoto, Y., Kinugasa, Y., Takagane, A., Endo, T., Shinozaki, H., Takii, Y., Mochizuki, H., Kotake, K., Kameoka, S., Takahashi, K., Watanabe, T., Watanabe, M., Boku, N., Tomita, N., Nakatani, E., Sugihara, K.
Publicado em 2014